Skip to content
A Green Sign – Lifestyle
Author:
Sutro Biopharma, Inc.
Sutro Biopharma Reports Second Quarter 2026 Financial Results and Provides Early Update on STRO-004 Phase 1 Study
August 12, 2026
Sutro Biopharma Reports First Quarter 2026 Financial Results and Business Highlights
May 14, 2026
Sutro Biopharma Presents Promising Preclinical Data Across its Pipeline of Next-Generation Single and Dual-Payload ADC Programs at AACR 2026
April 19, 2026
Sutro Biopharma Reports Full Year 2025 Financial Results and Business Highlights
March 24, 2026
Sutro Biopharma to Participate in Upcoming Investor Conferences
March 5, 2026